With earnings now out of the way, ACOR (Acordia Therapeutics Inc.) will be added as an Active Long Swing Trade as the stock appears poised for a breakout above this downtrend line following the recent divergent low.
ACOR daily 2 Nov 5th
The price targets are T1 at 2.65, T2 at 3.03 & T3 at 3.96 with the potential for an additional price target around the intersecting primary (upper-most) downtrend line + 5.55-6.46 resistance zone. The suggested stop is any print of 1.85 or below with a suggested beta-adjusted position size of 0.65, to account for the above-average gain loss potential of this low-priced, aggressive biotech stock. The idea entry range is between 2.28-2.55 with the stock trading around 2.42 now.